With durable competitive advantages, strong credit, and a well-stocked pipeline of new pharmaceuticals, Roche offers a 40% upside and a 7% annual return to investors willing to swallow this pill.
Rundown
Company name: Roche Holding AG
Ticker: RO (Swiss Exchange)
Type: Common stock bearer shares (with voting rights)
52-week range: SFr341-439
Market cap: SFr261…